By identifying new biomarkers, the researchers may be able to develop a test that is better at diagnosing Lyme early.

Wednesday, October 16, 2019 Scientists Work Toward a Rapid Point-of-Care Diagnostic Test for Lyme Disease Lyme disease can be difficult to diagnose because it causes a wide range of symptoms, from fever and rash to neurologic and cardiac symptoms and joint pain. Current Lyme disease tests also can miss an infection and provide a false negative, if they are performed too early. In a new study, NIAID-supported researchers have identified a new set of biomarkers for Lyme disease. These biomarkers could be used to develop better, faster tests for Lyme disease, which could provide more specific results in the early stages of infection. National Institute of Allergy and Infectious Diseases  |  National Institutes of Health Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107